JPMorgan Chase & Co’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10
| Closed | – | – | 6482 |
|
|
2023
Q1 | $0 | Buy |
10
+9
| +900% | – | ﹤0.01% | 6393 |
|
|
2022
Q4 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 6209 |
|
|
2022
Q3 | $0 | Sell |
2
-30
| -94% | – | ﹤0.01% | 6051 |
|
|
2022
Q2 | $0 | Buy |
32
+4
| +14% | – | ﹤0.01% | 6134 |
|
|
2022
Q1 | $0 | Buy |
28
+26
| +1,300% | – | ﹤0.01% | 6146 |
|
|
2021
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 6080 |
|
|
2021
Q3 | – | Sell |
-761
| Closed | -$53K | – | 5889 |
|
|
2021
Q2 | $53K | Buy |
761
+758
| +25,267% | +$52.8K | ﹤0.01% | 4936 |
|
|
2021
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 5465 |
|